通过KLVFFFF抑制β-粉样蛋白聚合的分子机制
Kevin Cobos-Montes1,2, Sebastián E Fuentes2, Francisca Estuardo2
1Departamento de Ciencias Químicas y Centro de Investigación para el Diseño de Materiales, Facultad de Ciencias Exactas, Universidad Andrés Bello, Sede Concepción, Talcahuano 4260000, Chile.
Journal of chemical information and modeling
|December 24, 2025
概括
该KLVFF通过分离单体而不是通过聚合来破坏β-粉样蛋白 (Aβ) 寡合体的稳定. 这种机制抑制了阿尔茨海默氏症.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 计算生物学 计算生物学
背景情况:
- β-粉样蛋白 (Aβ) 寡合体积累是神经退行性疾病的核心,如阿尔茨海默氏症.
- 众所周知,来自Aβ的KLVFF可以干扰Aβ聚合.
- KLVFF 作用的精确分子机制尚不清楚.
研究的目的:
- 阐明KLVFF与Aβ寡合体相互作用和抑制的分子机制.
- 在Aβ寡合体模型上研究KLVFF的结合部位和动态.
- 为了确定KLVFF是否会自我聚合或促进粉样类相互作用.
主要方法:
- 用不同数量的KLVFF (n=1,3,6) 的Aβ六合体模型进行分子动力学 (MD) 模拟.
- 对-寡合体相互作用的分析,重点关注结合点和动态.
- 实验验证使用循环二元化和 thioflavin T 聚合试验.
主要成果:
- KLVFF与Aβ寡合体的侧面和末端单体有动态相互作用,向疏水区域.
- 没有发现KLVFF聚合或粉样纤维末端相互作用的证据.
- KLVFF结合会诱导形状变化,导致终端单体脱离和寡合物的不稳定.
- 实验测定证实,KLVFF以剂量和时间依赖的方式减少Aβ溶液中的β片形成,并且自我聚合最小.
结论:
- KLVFF通过破坏寡合体结构和防止有序单体添加来抑制Aβ聚合,而不是通过自我聚合.
- KLVFF作为纤维末端不稳定剂,为阿尔茨海默病治疗提供了一种新的抑制机制.
- 这些发现指导了基于KLVFF机制的新Aβ聚合抑制剂的设计.
更多相关视频
06:27Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018
9.7K
04:41Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
23.8K
相关概念视频
03:03Amyloid Fibrils
11.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.5K
03:03Amyloid Fibrils
6.2K
6.2K